Horizon Finance (HRZN) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
6 May, 2026Executive summary
Completed merger with Monroe Capital Corporation (MRCC), issuing 20.4 million shares and receiving $141.1 million in cash, significantly increasing equity capital and scale; former MRCC stockholders now own 29.86% of the combined company.
Formed RoHo joint venture with ROTH Capital/CR Financial Holdings to provide growth financing to small and micro-cap public companies.
Achieved second consecutive quarter of portfolio growth, funding five investments totaling $120 million and growing total portfolio to nearly $700 million.
Declared regular and special cash distributions totaling $0.27 per share for Q3 2026, reflecting confidence in future earnings and spillover income.
Focus remains on secured debt investments in technology, life science, healthcare information/services, and sustainability sectors.
Financial highlights
Net investment income for Q1 2026 was $9.0 million ($0.19 per share), down from $10.7 million ($0.27 per share) year-over-year; NAV per share at $6.98 at quarter end.
Total investment income for Q1 2026 was $24.1 million, down from $25 million in Q1 2025, mainly due to lower fee-related income.
Portfolio yield on debt investments reached 15.2%, among the highest in the BDC industry.
Total expenses were $14.8 million, up from $13.4 million in Q1 2025; interest expense was $8.2 million, $0.5 million lower year-over-year.
Net realized loss on investments was $0.2 million; net unrealized depreciation was $4.6 million, a significant improvement from $32.2 million in the prior year.
Outlook and guidance
Expect continued portfolio growth in Q2 and beyond, driven by a strong pipeline and increased capital base.
Anticipate NII will cover declared distributions over time, supported by expanded capital and predictive pricing strategy.
Board declared regular and special monthly distributions for Q2 and Q3 2026.
Management expects current cash, operations, and credit facilities to be sufficient for at least the next 12 months.
Expect to record a one-time $4.3 million transaction expense in Q2 related to the merger.
Latest events from Horizon Finance
- Q4 portfolio growth, 14.3% yield, $647M assets, and merger set for future expansion.HRZN
Q4 202527 Mar 2026 - Supplemental distributions proposed to enhance shareholder value amid merger approval process.HRZN
Proxy Filing11 Mar 2026 - Merger creates a $446M NAV BDC, delivering a 33% NAV premium and scale benefits.HRZN
Q2 20253 Feb 2026 - NII and NAV fell, but 15.9% yield and strong liquidity support H2 2024 growth outlook.HRZN
Q2 20242 Feb 2026 - Net investment income fell, but portfolio growth and strong liquidity supported distributions.HRZN
Q3 202417 Jan 2026 - NII covered distributions in 2024, but NAV fell; strong yield and liquidity support 2025 growth.HRZN
Q4 202425 Dec 2025 - Vote sought on new investment management agreement; Board recommends approval for continuity.HRZN
Proxy Filing1 Dec 2025 - Shareholders will vote on director elections and auditor ratification, with robust governance in place.HRZN
Proxy Filing1 Dec 2025 - Shareholders to vote on a new investment management agreement after adviser's change in control.HRZN
Proxy Filing1 Dec 2025